Table 1.
Case numbers of the cohorts in the study
| Melanoma | Breast cancer | Prostate cancer | ||||
| N | % | N | % | N | % | |
| Basic population (cohort A) |
1,503 | 100 | 5,248 | 100 | 4,738 | 100 |
| non eligible patients (cohort B) |
741 | 49.3 | 2,882 | 54.9 | 2,512 | 53.0 |
| eligible patients (cohort C) |
762 | 50.7 | 2,366 | 45.1 | 2,226 | 47.0 |
| Participants (cohort F) |
608 | 40.5 * [79.8] |
1,927 | 36.7 * [81.4] |
1,750 | 36.9 * [78.6] |
| Non-respondents (cohort E) |
154 | 10.2 [20.2] |
439 | 8.4 [18.6] |
476 | 10.0 [21.4] |
| Non-participants (cohort D) |
895 | 59.5 | 3,321 | 63.3 | 2,988 | 63.1 |
* The value without parenthesis describes the study size (Percentage of the participants to the basic population). The value with parenthesis describes the recruiting efficiency proportion (Percentage of the participants to the eligible patients)